Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Dr., Bethesda, MD 20892-1088, USA;
Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Dr., Bethesda, MD 20892-1088, USA;
Division of Computational Bioscience, Center for Information Technology, NIH,Bethesda, MD, 20892, USA;
Biomedical Engineering and Physical Science Shared Resource,National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, MD 20892, USA;
Division of Computational Bioscience, Center for Information Technology, NIH,Bethesda, MD, 20892, USA;
Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Dr., Bethesda, MD 20892-1088, USA;
Molecular Imaging Program, National Cancer Institute, NIH, 10 Center Dr., Bethesda, MD 20892-1088, USA;
photodynamic therapy; trastuzumab; her2; activatable photosensitizer; tamra; rhodamine-b; rhodamine-6g;
机译:肽靶向光敏剂对黑素细胞的特异性靶向作用用于光动力治疗
机译:合成64Cu螯合的卟啉光敏剂及其肿瘤靶向肽结合物,用于评估靶细胞摄取和靶向光动力疗法药物的基于PET图像的药代动力学
机译:特定假鼠铜绿假单胞菌识别和靶向光动力治疗的甘草缀合的光敏剂
机译:用于光动力放射治疗的靶细胞特异性抗体的光敏剂
机译:朝着目标的光动力疗法:合成和表征的氮丙啶醛环化的癌症靶向肽和细菌氯霉素光敏剂。
机译:肽靶向光敏剂对黑素细胞的特异性靶向用于光动力治疗
机译:PDGFRβ特异性亲自递送光敏剂IR700,是血管靶向的结直肠癌的光动力学治疗有效